As shown in Supplementary Figure 3A, the mRNA expression of ACE2 was significantly increased in colon adenocarcinoma, stomach adenocarcinoma, and pancreatic adenocarcinoma compared to their corresponding adjacent non-tumor tissues. This evidence concerns the gene ACE2 and pancreatic adenocarcinoma.